Bisphosphonates

This section contains links to information about the use of bisphosphonates such as clodronate (Bonefos), pamidronate (Aredia), alendronate (Fosamax), etidronate (Didronel), zoledronic acid (Zometa) or ibandronate (Bonviva) in the treatment of osteoporosis caused by prolonged hormone treatment of advanced prostate cancer.

Getting answers...
Show information for: |

Results for "Bisphosphonates"

# Title and Source Quality
1

Hormonal therapy for early prostate cancer

Source: Macmillan Cancer Support View all
Last updated: 01 February 2010
90%
2

Zoledronic acid (Zometa)

Source: CancerHelp UK View all
Last updated: 28 September 2009
85%
3

Bisphosphonates

Source: Prostate Cancer UK View all
Last updated: February 2009
79%
4

The use of bisphosphonates in men with hormone-refractory prostate cancer

Source: Centre for Reviews and Dissemination (CRD) View all
Last updated: 30 September 2008
75%
5

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Source: National Cancer Institute (NCI) View all
Last updated: July 16, 2008
73%
6

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Source: National Cancer Institute (NCI) View all
Last updated: May 27, 2008
73%
7

Bisphosphonates for advanced prostate cancer (Cochrane Review)

Source: The Cochrane Library View all
Last updated: 2006
58%
8

Bisphosphonates in early prostate cancer (Protocol for a Cochrane Review)

Source: The Cochrane Library View all
Last updated: 2006
58%